Creo Medical Group

Advanced Energy Platforms Will Boost Secular Demand In Healthcare

AnalystHighTarget

Not Invested

Consensus Narrative from 3 Analysts

Published

13 Aug 25

Updated

21 Aug 25

AnalystHighTarget's Fair Value

UK£1.02

86.5% undervalued

21 Aug

UK£0.14

-52.6%

-0.9%

Author's Valuation

UK£1.0

86.5% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

UK£1.0

86.5% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

38.79%

Medical Equipment revenue growth rate

0.44%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.79%

Calculation

UK£2.82m

Earnings '28

250.39x

PE Ratio '28

UK£706.24m

Market Cap '28

UK£706.24m

Market Cap '28

552.88m

No. shares '28

UK£1.28

Share Price '28

UK£1.28 Share Price '28

Discounted to 2025 @ 7.79% p.a.

UK£1.02

Fair Value '25